Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Zuma, Branson Collaborate To Establish Disease Control Center In South Africa
South African President Jacob Zuma and Virgin Group founder and chair Richard Branson "intend [on] establishing a disease control centre in South Africa as soon as next year," SAPA/The Times reports. "Branson said the initiative, expected to be launched by March, would be 50 percent private and 50 percent government funded," the news service writes (7/22).

Youth Baseball-Related Injuries Down 25 Percent, National Study Finds
Spring marks baseball season for more than 19 million children and adolescents who play each year as part of a team or in backyards throughout the United States. The good news for these players is that the number of injuries from the sport is on the decline. A new study by the Center for Injury Research and Policy of The Research Institute at Nationwide Children"s Hospital found that the number of children and adolescents treated for baseball-related injuries in hospital emergency departments decreased 25 percent from 1994 through 2006 - going from an estimated 147,000 injuries in 1994 to approximately 111,000 injuries in 2006. This is the first national study of youth baseball injuries requiring emergency treatment, and is now available online in the June electronic issue of Pediatrics.
News of the day
Novel Non-Surgical Therapy Dramatically Increases Weight Loss In Obese Patients; Results From Pilot Clinical Study Presented At ASMBS
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced results from a pilot clinical study which demonstrated the substantially enhanced weight loss effects of combining the company"s EndoBarrier Gastrointestinal Liner with a new EndoBarrier Flow Restrictor. The EndoBarrier Flow Restrictor provides an adjustable restriction at the outlet of the stomach and is designed to delay gastric emptying, an additional mechanism which adds to the therapeutic effects of the liner. The results were presented today at the 26th annual meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS).
Diagnostics

Medtronic And Abbott Laboratories Resolve Global Vascular Patent Disputes

Medtronic, Inc. (NYSE: MDT) announced global resolution of all outstanding intellectual property litigation with Abbott Laboratories. Terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least 10 years, subject to certain conditions. The agreement includes a $400 million settlement payment to be made to Abbott and also results in a $42 million success payment to evYsio Medical Devices, LLC, as part of a Medtronic sublicense to Abbott of the evYsio stent design technology. In connection with the settlement, Medtronic expects to report in its first quarter financial results a special charge to be calculated in accordance with generally accepted accounting principles. Following the resolution of these disputes with Abbott, Medtronic has now resolved or settled substantially all intellectual property litigation affecting the stent design and stent delivery systems of its bare metal and drug-eluting stent franchise. As a result, Medtronic will now focus more res on efforts to improve health care for patients with vascular disease. Medtronic


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009